BioGenex Laboratories
1981
FOUNDED
PUBLIC
STATUS
201-300
EMPLOYEES
BGNX
STOCK SYMBOL
Description
Provider of automated systems that streamline operations in anatomic pathology and tools for the detection and diagnosis of cancer and infectious diseases. The company offers monoclonal and polyclonal antibodies for immunohistochemistry (IHC) staining on formalin-fixed, paraffin-embedded tissue, as well as for detecting a range of antigens.
Primary Industry
Diagnostic Equipment
Other Industries
Other Pharmaceuticals and Biotechnology
Primary Office
- 4600 Norris Canyon Road
- San Ramon, CA 94583
- United States
+1 (925) 000-0000
Request full access to PitchBook
You’re viewing a free company profile from the PitchBook Platform. To explore BioGenex Laboratories’s full profile, request a free trial.
BioGenex Laboratories Financials Summary
|
In Thousands,
USD |
TTM
31-Dec-2010
|
FY 2010
31-Dec-2010
|
FY 2009
31-Dec-2009
|
FY 2008
31-Dec-2008
|
|---|---|---|---|---|
| Revenue | 14,364 | 14,364 | 16,850 | 15,553 |
Public Fundamental Data provided by Morningstar, Inc.
disclaimer
BioGenex Laboratories Valuation and Funding
| Deal Type | Date | Amount | Post-Val | Valuation/ EBITDA |
Debt | Status |
|---|
This information is reserved for PitchBook Platform users. To explore BioGenex Laboratories‘s full profile, request access.
Request full access to PitchBookBioGenex Laboratories Executive Team (3)
| Name | Title | Board Seat |
Contact Info |
|---|---|---|---|
| Krishan Kalra Ph.D | Founder, Chairman & Chief Executive Officer | ||
| David Sheldon | Chief Financial Officer | ||
| George Su Ph.D | Director, Operations |
BioGenex Laboratories Board Members (1)
| Name | Representing | Role | Since | Contact Info |
|---|---|---|---|---|
| 0000000 00000 00.0 | BioGenex Laboratories | Founder, Chairman & Chief Executive Officer | 000 0000 |